PE Ratio
25.34
+0.42+1.69%
Sat, 08 Mar 2025 00:46:39 GMT
Summary
- As of March 8, 2025, GSK price to earnings ratio is 25.34, with a rise of +0.42 (+1.69%) during the most recent trading day.
- Over the past year, GSK PE ratio has increased by +10.72 (+73.32%).
- GSK PE ratio is now -98.16% below its all-time high of 1376.28.
Performance
GSK PE Ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
PE Ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
GSK PE Ratio Trends
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | +1.7% | +1.7% | +2.9% | +1.0% |
| 1 m1 month | +11.3% | +11.3% | - | - |
| 3 m3 months | +15.6% | +15.6% | 0.0% | 0.0% |
| 6 m6 months | +43.7% | -8.1% | - | - |
| ytdytd | +18.6% | +18.7% | - | - |
| 1 y1 year | +73.3% | -8.3% | 0.0% | 0.0% |
| 5 y5 years | +73.2% | -7.2% | -54.0% | +9.9% |
GSK PE Ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | at high | 22.61 | +12.1% | |
| 3 m | 3-month | 25.34 | at high | 20.21 | +25.4% |
| 6 m | 6-month | 26.48 | -4.3% | 16.38 | +54.7% |
| 1 y | 1-year | 26.48 | -4.3% | 13.98 | +81.3% |
| 3 y | 3-year | 26.48 | -4.3% | 3.53 | +617.9% |
| 5 y | 5-year | 26.48 | -4.3% | 3.53 | +617.9% |
| alltime | all time | 1376.28 | -98.2% | 3.53 | +617.9% |
GSK PE Ratio History
| Date | Value |
|---|---|
| 2025 | 25.33(+18.6%) |
| 2024 | 21.36(+72.8%) |
| 2023 | 12.36(+205.9%) |
| 2022 | 4.04(-73.2%) |
| 2021 | 15.05(+45.8%) |
| 2020 | 10.32(-36.4%) |
| 2019 | 16.22(0.0%) |
| 2018 | 16.22(-56.3%) |
| 2017 | 37.11(-44.5%) |
| 2016 | 66.81(+967.3%) |
| 2015 | 6.26(-66.7%) |
| 2014 | 18.82(+51.4%) |
| 2013 | 12.43(+0.4%) |
| 2012 | 12.38(+10.1%) |
| 2011 | 11.24(-65.5%) |
| 2010 | 32.54(+221.5%) |
| 2009 | 10.12(+9.3%) |
| 2008 | 9.26(-15.2%) |
| 2007 | 10.92(-11.6%) |
| 2006 | 12.35(-10.6%) |
| Date | Value |
|---|---|
| 2005 | 13.82(-11.7%) |
| 2004 | 15.65(+3.5%) |
| 2003 | 15.12(-2.2%) |
| 2002 | 15.46(-45.2%) |
| 2001 | 28.20(+24.0%) |
| 2000 | 22.74(-17.4%) |
| 1999 | 27.54(-19.0%) |
| 1998 | 33.98(+44.2%) |
| 1997 | 23.56(+64.0%) |
| 1996 | 14.37(-33.7%) |
| 1995 | 21.68(+42.5%) |
| 1994 | 15.21(+17.6%) |
| 1993 | 12.93(-22.6%) |
| 1992 | 16.71(-60.7%) |
| 1991 | 42.54(+18.2%) |
| 1990 | 35.98(+3.4%) |
| 1989 | 34.81(+23.0%) |
| 1988 | 28.31(-6.5%) |
| 1987 | 30.29(-18.4%) |
| 1986 | 37.11(-55.2%) |
| 1985 | 82.81 |
FAQ
- What is GSK price to earnings ratio?
- What is the all time high PE ratio for GSK?
- What is GSK price to earnings ratio year-to-date change?
- What is GSK PE ratio year-on-year change?
What is GSK price to earnings ratio?
The current PE ratio of GSK is 25.34
What is the all time high PE ratio for GSK?
GSK all-time high price to earnings ratio is 1376.28
What is GSK price to earnings ratio year-to-date change?
GSK price to earnings ratio has changed by +3.98 (+18.63%) since the beginning of the year
What is GSK PE ratio year-on-year change?
Over the past year, GSK price to earnings ratio has changed by +10.72 (+73.32%)